UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021171
Receipt number R000024412
Scientific Title Assessment of feasibility of sentinel node mapping by indocyanine green fluorescence imaging and metastatic diagnosis by one-step nucleic acid amplification in laparoscopic gastric cancer surgery
Date of disclosure of the study information 2016/02/25
Last modified on 2023/09/07 16:08:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of feasibility of sentinel node mapping by indocyanine green fluorescence imaging and metastatic diagnosis by one-step nucleic acid amplification in laparoscopic gastric cancer surgery

Acronym

Assessment of validity of sentinel node mapping by indocyanine green fluorescence imaging in laparoscopic gastric cancer surgery

Scientific Title

Assessment of feasibility of sentinel node mapping by indocyanine green fluorescence imaging and metastatic diagnosis by one-step nucleic acid amplification in laparoscopic gastric cancer surgery

Scientific Title:Acronym

Assessment of validity of sentinel node mapping by indocyanine green fluorescence imaging in laparoscopic gastric cancer surgery

Region

Japan


Condition

Condition

Early gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess the clinical availability of the combination of the sentinel node detection by indocyanine green fluorescence imaging and the metastatic diagnosis by one-step nucleic acid amplification in laparoscopic gastric cancer surgery.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

identification rate of fluorescent nodes

Key secondary outcomes

1)Durations of tracer administration, sentinel node mapping and diagnosis by one-step nucleic acid amplification.
2)Number of detected sentinel nodes
3)Distribution of sentinel nodes
4)Incidence rate of adverse events and postoperative complications


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

To detect sentinel nodes, the tracer (indocyanine green solution) is administrated to the submucosa around the primary tumor at the beginning of surgery.
Stained/fluorescent nodes are harvested intracorporeally prior to gastrectomy. Study subjects will be performed gastrectomy according to gastric cancer treatment guideline.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) age >= 20
2) clinically T1N0M0 gastric cancer
3) single lesion
4) less than 4cm in diameter
5) out of indication for endoscopic resection
6) biopsy from the primary lesion is positive for CK19
7) BMI <=25
8) The patient who give prior concent to join this study
9) the type of biopsy specimen does not matter

Key exclusion criteria

1) the past history of gastric resection or the endoscope treatment
2) the case with tumor invading to esophagus or duodenum
3) a pregnant woman, patients having drug (iodo) allergy career or the asthma
4) the case which the physician judged as the inappropriate case to participate in this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Souya
Middle name
Last name Nunobe

Organization

Cancer Institute Hospital, Japanese Foundation for Cancer Research

Division name

Gastroenterological surgery

Zip code

135-8550

Address

3-8-31, Ariake, Koto, Tokyo 135-8550, Japan

TEL

03-3520-0111

Email

souya.nunobe@jfcr.or.jp


Public contact

Name of contact person

1st name Koshi
Middle name
Last name Kumagai

Organization

Cancer Institute Hospital, Japanese Foundation for Cancer Research

Division name

Gastroenterological surgery

Zip code

135-8550

Address

3-8-31, Ariake, Koto, Tokyo 135-8550, Japan

TEL

03-3520-0111

Homepage URL


Email

koshi.kumagai@jfcr.or.jp


Sponsor or person

Institute

Cancer Institute Hospital, Japanese Foundation for Cancer Research

Institute

Department

Personal name



Funding Source

Organization

Sysmex Corporation

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Cancer Institute Hospital, Japanese Foundation for Cancer Research

Address

3-8-31, Ariake, Koto, Tokyo 135-8550, Japan

Tel

03-3520-0111

Email

med.shinsa@jfcr.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

公益財団法人 がん研究会有明病院


Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 07 Month 12 Day

Date of IRB

2016 Year 12 Month 28 Day

Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 24 Day

Last modified on

2023 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024412